The HIV viral entry co-receptors CCR5 and CXCR4 function physiologically as typical chemokine receptors. Activation leads to cytosolic signal transduction that results in a variety of cellular responses such as cytoskeletal rearrangement and chemotaxis (CTX). Our aim was to investigate the signalling pathways involved in CC-and CXC-receptor mediated cell migration. Inhibition of dynamin I and II GTPase with dynasore completely inhibited CCL3 stimulated chemotaxis in THP-1 cells, whereas the dynasore analogue dyngo-4a, which is a more potent inhibitor, showed reduced ability to inhibit CC-chemokine induced CTX. In contrast, dynasore was not able to block cell migration via CXCR4. The same activation/inhibition pattern was verified in activated-T-lymphocytes for different CC-and CXC-chemokines. Cell migration induced by CC-and CXC-receptors is not relying on active internalisation processes driven by dynamin since the blockade of internalisation does not affect migration, but they might rely on dynamin interaction with the cytoskeleton. We identify here a functional difference in how CC-and CXC-receptor migration is controlled, suggesting that specific signalling networks are being employed for different receptor classes and potentially specific therapeutic targets to prevent receptor migration can be identified.
Introduction
Cellular migration can be activated by chemokine receptors, which are part of the G protein coupled receptors family (GPCRs) [1] . In different disease settings and different cancer types it has been shown that chemokine receptors play a crucial role in promoting cell migration and even cancer growth [2, 3] . Several chemokines (CCL5, CCL8) act as agonists for CCR1, CCR3 and CCR5, whereas a few chemokines, like CCL2, only activate CCR2 and CCR4, but not CCR5 [4, 5] . It has been shown that chemokine receptor activation leads to activation of heterotrimeric G proteins and phosphorylation of the receptor via G protein coupled receptor kinases (GRKs), which in turn leads to binding of β-arrestins to the receptor and is followed by receptor internalisation [4] . Activation is also followed by actin polymerisation but the signalling networks become which activated to allow this to
happen have yet to be fully defined.
In recent years it has become clear that GPCRs do not signal solely via G proteins [6] . The so called receptosome of these receptors, which includes β-arrestins and other associating proteins makes signalling of GPCRs comparatively complex. β-arrestins can associate directly with a range of proteins including ERK1/2, cofilin, filamin and Jnk3 and therefore activate a variety of cellular responses without the involvement of G proteins [7] . Ligand biased signalling is important for chemokine Dynamins are large multi-domain proteins (∼100 kDa) that constitute an N-terminal GTPase domain, a middle domain, a PH domain, a GTPase effector domain (GED), and a C-terminal proline-rich domain (PRD), which interacts with proteins that contain SH3 domains [21] and there are several types of the protein: dynamin I is primarily found in neurones where it is involved in synaptic vesicle endocytosis [22, 23] and it has been linked with several neurological processes such as long-term memory formation [24] . Dynamin II is ubiquitously expressed and is found in all cell types, dynamin III is primarily found in the testis. Dynamin II interacts with numerous
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Here we analysed different small molecule inhibitors for their effects on chemokine receptor-induced migration and release of intracellular calcium. We investigated whether dynamin plays a role for both CC-receptor-as well as CXC-receptorinduced migration or whether distinct signalling pathways are activated by different subsets of receptors.
Methods

Cells and materials
Culture conditions for THP-1 cells have previously been described [9] . Jurkat cells were obtained from ATCC and grown in RPMI containing 10% FCS and 2 mM Lglutamine. Blood was sampled from healthy normal subjects according to a protocol approved by a local ethics committee (reference number 2008042). Peripheral blood mononuclear cells (PBMCs) were subsequently isolated as previously described by Sabroe et al. [27] . Lymphocytes were separated from monocytes by allowing the latter to adhere to a tissue culture flask for 2 hours at 37 °C and 5% CO 2 and were activated by culture in the presence of IL-2 (200 mg/mL) and concanavalin A (30 mg/mL) for at least 10 days. The chemokine used for CCR5/CCR1 activation was human CCL3 (D26A) and has been described before [9, 28] . CXCL11 and CXCL12
were from Peprotech (UK). Dynamin inhibitors dynasore, dyngo-4a, MiTMAB, OcTMAB, dynole-34-2, dynole-31-2 (negative control), iminodyn-22 and iminodyn-17
(negative control), pyrimidin-7 were purchased from Abcam (for an overview of dynamin inhibitors see hours before cells were counted. Data was analysed as previously described [15] .
Analysis of data
Data were analysed using GraphPad Prism 5 (GraphPad Software). Statistical analyses were performed using a one-way ANOVA with a Bonferroni multiple comparison test as post-hoc test with a p value <0.05 deemed significant. In all figures, data represent the mean ± S.E.M. of at least three independent experiments. The dynasore analogue dyngo-4a, which is more potent than dynasore (dyngo-4a IC 50 16±1.2 µM versus dynasore 79.3±1.3 µM [30] ) blocks migration towards CCL3
Results
in THP-1 cells to a lesser degree than dynasore. Remarkably dyngo-4a blocks Figure 2 ). Dyngo-4a shows selectivity towards dynamin I versus dynamin II whereas dynasore is non-selective and therefore these results might reflect a different usage of the dynamin isoforms by different receptors (see Table 1 ). We further investigated which domains of the dynamin proteins are essential for cell migration and whether they are equally important for different receptor families. In the first instance, we used iminodyn-22 and dynole-34-2 which are both non- Dynamin is classically known as being of importance for clathrin-coated pit triggered internalisation of receptors, even though recently its importance for actin-dynamics have become more apparent [19] . We previously showed that CCR5 can use 
Discussion
In this study we investigated the role of dynamin in the signalling events that occur after the activation of CC-and CXC-receptors. Dynamin involvement in cell migration is related to its role as a focal adhesion regulator and it has been shown that inhibition of dynamin 2 inhibits focal adhesion disassembly and impairs cell migration.
We, therefore, used different dynamin inhibitors, which either have a higher potency for dynamin I over II (dyngo-4a) or are non-selective dynamin I and II inhibitors (dynasore, dynole-34-2, MiTMAB, OcTMAB, iminodyn-22, pyrimidyn-7) [30, 32, 33] .
Dynasore has been shown previously to block endocytosis via clathrin-coated pits [34] [35] [36] and indeed it blocks CCL3-induced endocytosis of CCR5 in CHO.CCR5 cells.
Dynasore blocks CCL3 induced migration in THP-1 cells and activated Tlymphocytes, but it has no effect on either CXCL12-induced migration of THP-1 or Jurkat cells or CXCL11-induced migration of activated T-lymphocytes. These results point towards a significant difference between CC-and CXC-receptor activated signalling networks. Dyngo-4a, a close analogue of dynasore, which is more potent than dynasore and has a higher potency for dynamin I over dynamin II [30] , We, therefore, employed a different clathrin-coated pits endocytosis inhibitor, pitstop 2 and its negative control compound to analyse whether internalisation is a prerequisite for migration. In both THP-1 cells and Jurkat cells pitstop 2 did not prevent CCL3-and CXCL12-induced migration, respectively, which is evidence that receptor internalisation is not necessary to activate cell migration as had been described already for the CCR2b receptor [37] .
In our study we detect distinct differences between the CC-and CXC-receptors.
Traditionally it has been shown that CXCR4 activation leads to chemotaxis in a β-arrestin 2, ERK 1/2, Gβγ dependent manner and is PI3K dependent [38, 39] .
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